Post by
subaru1i on Mar 27, 2024 3:59pm
Start CC audio at 5:00 minutes: Management feels their stock
price is UNDERVALUED....I have known that for a LONG time but WHY is management high lighting this now? It's a no brainer with the DEA rescheduling any day now and LABS is the ONLY FDA approved pharmaceutical company in NORTH AMERICA capable of supplying cannbinoid pharmaceutical molecules for pharmaceutical appications.
PIDDUCK BROUGHT THIS PUBLICLY FOR A REASON.
Comment by
mdjbrown on Mar 27, 2024 4:04pm
s1i, heres an out of the box thought - Would it be surprising to hear STADA takes a run at Medipharm Multi billion dollar company getting into medicinal CBD sales in a country about to let loose in 4 days.
Comment by
okgonow on Mar 27, 2024 4:08pm
it would be a cash deal cause im pretty sure they are a private company
Comment by
mdjbrown on Mar 27, 2024 4:14pm
Agree okgonow Very interesting that all of a sudden Medipharm execs are making sure everyone knows the company share price is undervalued, when previously they didnt seem too concerned. That is until they loaded up with RSU's. Coincidence?
Comment by
subaru1i on Mar 27, 2024 4:18pm
STADA could try that but you don't get over 20 clinical trials funded by a global pharma partner and turn your back on the global pharma partner that you worked with...that imho would be a legal mess. Still sticking to my gun....Pfizer all the way.